BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 1082364)

  • 1. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.
    Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC
    Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
    Marroum MC; Huvos AG; Rosen G
    Oncology; 1977; 34(6):273-80. PubMed ID: 304199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
    Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
    Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.
    Huvos AG; Rosen G; Marcove RC
    Arch Pathol Lab Med; 1977 Jan; 101(1):14-8. PubMed ID: 299812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.
    Beattie EJ; Martini N; Rosen G
    Cancer; 1975 Mar; 35(3):618-21. PubMed ID: 1078639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limb preservation in osteogenic sarcoma: a preliminary report.
    Jaffe N; Watts H; Frei E; Traggis D; Vawter G; Fellows K
    Recent Results Cancer Res; 1977; (62):114-22. PubMed ID: 304589
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
    Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
    Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
    Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
    Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma.
    Rosen G; Tefft M; Martinez A; Cham W; Murphy ML
    Cancer; 1975 Mar; 35(3):622-30. PubMed ID: 1078640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee.
    Zhang C; Hu J; Zhu K; Cai T; Ma X
    Int Orthop; 2018 Apr; 42(4):927-938. PubMed ID: 29427125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. En bloc resection for osteogenic sarcoma.
    Marcove RC
    Can J Surg; 1977 Nov; 20(6):521-8. PubMed ID: 271035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E; Wilbur JR
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
    Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
    Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
    Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Custom prosthetic reconstruction for proximal tibial osteosarcoma with proximal tibiofibular joint involved.
    Zhang Y; Yang Z; Li X; Chen Y; Zhang S; Du M; Li J
    Surg Oncol; 2008 Aug; 17(2):87-95. PubMed ID: 18160278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].
    Muñoz Villa A; Ocete G; Aymerich ML; Maldonado S; Otheo E; Calvo M; Amaya J
    Med Clin (Barc); 1996 Jun; 107(5):161-4. PubMed ID: 8758673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. En bloc resections for osteogenic sarcoma.
    Marcove RC; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):165-8. PubMed ID: 6946289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.